Multiple Sclerosis Clinical Trials

Showing 2821-2839 of 2,839 trials

Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma

NCT00294177

Gestational trophoblastic disease comprises a spectrum of diseases with different propensity for local invasion and metastasis, that is, partial and complete hydatidiform mole, choriocarcinoma, and placental site trophoblastic tumor.All trophoblastic tumors produce hCG, and monitoring of therapy is largely based on the determination of hCG in serum. The conformational change of tumor markers during antineoplastic chemotherapy for cancer and its clinical meaning has only been rarely studied. In this study, we will try to understand the conformational change of the tumor marker (hCG) during chemotherapy.

Trophoblastic NeoplasmsChoriocarcinoma

National Taiwan University Hospital30 participantsStarted Aug 2006

Taipei, Taipei, Taiwan

UNKNOWN

Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up

NCT00289159

To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after treatment with interferon.

Multiple Sclerosis

Groupe Hospitalier Pitie-Salpetriere

COMPLETEDPhase 4

Mouth Care Regimes During Radiotherapy

NCT00138827

The purpose of this study is to assess whether Biotene oral care products have a benefit in the treatment of xerostomia and mucositis when compared with conventional bicarbonate mouth care regimes.

Head and Neck Neoplasms

St George Hospital, Australia50 participantsStarted Nov 1999

Sydney, New South Wales, Australia

UNKNOWNPhase 3

Boost Use in Breast Conservation Radiotherapy

NCT00138814

This is a two arm randomized study for patients who are undergoing radiotherapy following breast conservation surgery for breast cancer. Local recurrence of breast cancer will be compared for patients receiving boost or no boost radiotherapy.

Breast Neoplasms

St George Hospital, Australia680 participantsStarted Jan 1997

Sydney, New South Wales, Australia • Sydney, New South Wales, Australia • Wollongong, New South Wales, Australia

Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma

Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up

Mouth Care Regimes During Radiotherapy

Boost Use in Breast Conservation Radiotherapy

Related Searches

A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

Clinical Usefulness of Optical Skin Biopsy

Study of NS-9 in Patients With Liver Metastases

A Comparison of Survey Methodologies to Elicit Sensitive Information From Adolescents in Urban India

MR-Lymphography and Lymph Node Staging in Prostate Cancer

Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI

Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients

Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma

Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients